Literature DB >> 23399564

Unexpected biotinylation using ATP-γ-Biotin-LC-PEO-amine as a kinase substrate.

Dhruv P Arora1, Elizabeth M Boon.   

Abstract

Protein phosphorylation is the most widely studied post-translational modification. Reversible protein phosphorylation is implicated in the regulation of a broad range of cellular processes. As such, there is extensive interest in simple and sensitive procedures for the isolation and detection of phosphorylated proteins. Synthetic analogues of ATP, with a biotin linked to the gamma-phosphate of ATP, have been reported to biotinylate kinase substrates in a kinase-catalyzed reaction. This could be an extremely attractive and versatile method for affinity enrichment of phosphorylated proteins. However, as we report here, the commercially available biotin-ATP analogue, ATP-γ-Biotin-LC-PEO-amine, is capable of biotinylating proteins independent of kinase activity. In fact, we demonstrate that this reagent is capable of non-specifically biotinylating any protein. Although the mechanism of biotinylation is not known, this report uncovers a flaw in a commercially available reagent and also highlights the importance of control experiments when developing new biochemical tools to study enzyme activity.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23399564     DOI: 10.1016/j.bbrc.2013.01.115

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  Discovery of Two Bacterial Nitric Oxide-Responsive Proteins and Their Roles in Bacterial Biofilm Regulation.

Authors:  Sajjad Hossain; Lisa-Marie Nisbett; Elizabeth M Boon
Journal:  Acc Chem Res       Date:  2017-06-12       Impact factor: 22.384

2.  The generality of kinase-catalyzed biotinylation.

Authors:  Chamara Senevirathne; D Maheeka Embogama; Thilani A Anthony; Ahmed E Fouda; Mary Kay H Pflum
Journal:  Bioorg Med Chem       Date:  2015-11-23       Impact factor: 3.641

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.